Cancer Treatments Using Low-Temperature Plasma

Curr Med Chem. 2021;28(41):8549-8558. doi: 10.2174/0929867328666210629121731.

Abstract

Low-temperature plasma (LTP) is a partially ionized gas that contains electrons, ions, radicals, light, etc. Recently, the bio-medical application of LTP has become a hot topic in plasma science and biological science. Cancer treatment with plasma is the most challenging topic in plasma bio-medical applications. Many in vitro and in vivo experiments have been conducted to investigate the anti-tumor effects of LTP. Extracellular reactive oxygen and nitrogen species (RONS) in plasma-activated solutions are key factors for the anti-tumor effects, and amino acid modifications by LTP may affect cellular responses. Intracellular RONS are also key factors for the anti-tumor effects. Various signaling pathways, such as p53 signaling pathways, survival and proliferation signaling pathways, and oxidative stress-dependent signaling pathways are activated by LTP.

Keywords: Low-temperature plasma; biochemical networks; plasma cancer therapy; plasma medicine; plasma-activated medium.; reactive oxygen species (ROS).

MeSH terms

  • Humans
  • Neoplasms* / drug therapy
  • Reactive Nitrogen Species*
  • Reactive Oxygen Species
  • Signal Transduction
  • Temperature

Substances

  • Reactive Nitrogen Species
  • Reactive Oxygen Species